B C Lund
Affiliation: University of Iowa
- Visual disturbance associated with celecoxibB C Lund
Clinical and Administrative Division, College of Pharmacy Iowa City, IA 52242 1112, USA
Pharmacotherapy 21:114-5. 2001..Similar visual disturbances described with the traditional nonsteroidal antiinflammatory drugs are discussed...
- Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approachB C Lund
Division of Clinical and Administrative Pharmacy, College of Pharmacy, University of Iowa, 443 S Pharmacy Bldg, Iowa City, IA 52242 1112, USA
Arch Gen Psychiatry 58:1172-6. 2001..However, investigators have been unable to clearly demonstrate this association when compared with a control group receiving conventional antipsychotics...
- Psychiatric prescribing trends and practices in Iowa's prisonsBrian C Lund
Pharmacoepidemiology, College of Pharmacy, University of Iowa, Iowa City, 52242 1112, USA
Psychiatr Serv 53:1023-4. 2002..The use of antipsychotics remained relatively constant, but expenditures increased ninefold. In contrast, both use of and expenditures for antidepressants increased tremendously, from $215 to $1,929 per 100 inmates...
- Olanzapine: an atypical antipsychotic for schizophreniaB C Lund
University of Iowa, College of Pharmacy, 443 S Pharmacy Building, Iowa City, IA 52242 1112, USA
Expert Opin Pharmacother 1:305-23. 2000..While generally considered first-line drugs from an efficacy and adverse effect standpoint, pharmacoeconomic studies are needed to justify the large acquisition cost of olanzapine compared to typical agents...
- Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine TrialP J Perry
Department of Psychiatry, College of Medicine, University of Iowa, Iowa City, USA
J Clin Psychopharmacol 21:14-20. 2001..2 ng/mL was a predictor of therapeutic response in acutely ill patients with schizophrenia. Males required a higher olanzapine dose to reach this threshold concentration than their female counterparts...
- Ziprasidone, a new atypical antipsychotic drugR M Carnahan
Clinical and Administrative Pharmacy Division, College of Pharmacy, University of Iowa, Iowa City 52242-1112, USA
Pharmacotherapy 21:717-30. 2001..In contrast, ziprasidone has a low propensity for causing weight gain. For patients requiring an antipsychotic drug, ziprasidone represents a new treatment option with a limited adverse effect profile...
- Bioavailable testosterone as a correlate of cognition, psychological status, quality of life, and sexual function in aging males: implications for testosterone replacement therapyP J Perry
Clinical and Administrative Pharmacy Division, College of Pharmacy, University of Iowa, Iowa City 52242 1112, USA
Ann Clin Psychiatry 13:75-80. 2001..Overall, bioavailable testosterone was not an important determinant of cognitive, psychological, or sexual functioning or of quality of life. The implications for future studies involving testosterone replacement therapy are discussed...
- Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychoticsC D Hatch
Clinical and Administrative Division, College of Pharmacy, University of Iowa, Iowa City 52242-1112, USA
Pharmacotherapy 21:1003-6. 2001..Few cases of quetiapine-induced NMS have been reported. A 54-year-old man was unsuccessfully challenged with quetiapine after conventional antipsychotic-induced NMS...
- Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adultsS Kuperman
Department of Psychiatry, College of Medicine, University of Iowa, Iowa City 52242, USA
Ann Clin Psychiatry 13:129-34. 2001..14). Neuropsychological testing demonstrated trends favoring drug treatment on measures of immediate recall and verbal fluency. While bupropion SR may be a viable clinical alternative for adults with ADHD, further investigation is needed...
- The association of weight gain and olanzapine plasma concentrationsPaul J Perry
Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA
J Clin Psychopharmacol 25:250-4. 2005..The association of weight gain with plasma concentrations during treatment with olanzapine may support the utilization of plasma drug concentration as a marker for antipsychotic-induced weight gain in the treatment of schizophrenia...
- Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapineVicki L Ellingrod
University of Iowa, College of Pharmacy, Iowa, USA
Am J Med Genet B Neuropsychiatr Genet 134:76-8. 2005..Weight gain from atypical antipsychotic use has become a significant problem. Recent reports have liked the -759 polymorphism of the 5HT2C receptor and obesity as well as weight gain from chlorpromazine, risperidone, and clozapine...
- The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice?Ryan M Carnahan
Clinical and Administrative Pharmacy, College of Pharmacy, University of Iowa, Iowa City, USA
J Am Geriatr Soc 52:2082-7. 2004..To measure the prevalence of anticholinergic use cross-sectionally in patients receiving cholinesterase inhibitors and to describe change in use of anticholinergics upon inception of cholinesterase inhibitor treatment...
- Evaluation of the Iowa Medicaid pharmaceutical case management programElizabeth A Chrischilles
Health Effectiveness Research Center, Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA 52242, USA
J Am Pharm Assoc (2003) 44:337-49. 2004..To test the effect of pharmaceutical case management (PCM) on medication safety and health care utilization...
- A longitudinal analysis of antihypertensive drug interactions in a Medicaid populationBarry L Carter
Division of Clinical and Administrative Pharmacy, College of Pharmacy S 511, University of Iowa, Iowa City, IA, USA
Am J Hypertens 17:421-7. 2004..Drug interactions are a frequent cause of adverse drug events. We evaluated whether the frequency of previously reported antihypertensive drug-drug interactions could be reduced by pharmaceutical case management...
- 5-HT2A receptor promoter polymorphism, -1438G/A and negative symptom response to olanzapine in schizophreniaVicki L Ellingrod
Clinical and Administrative Division, University of Iowa College of Pharmacy, Iowa City, Iowa, USA
Psychopharmacol Bull 37:109-12. 2003..We conclude that the A/A genotype may be associated with olanzapine negative symptom response, seen as a 2-fold greater percent reduction in SANS, and may be clinically relevant...
- Measures of aggression and mood changes in male weightlifters with and without androgenic anabolic steroid usePaul J Perry
Clinical and Administrative Pharmacy Division, College of Pharmacy, University of Iowa, Iowa City, IA 52246, USA
J Forensic Sci 48:646-51. 2003....
- Testosterone therapy in late-life major depression in malesPaul J Perry
Division of Clinical Pharmacy, College of Pharmacy, University of Iowa, Iowa City 52242, USA
J Clin Psychiatry 63:1096-101. 2002..The efficacy and safety of testosterone therapy in the treatment of depression in elderly hypogonadal males is inconclusive. The following study identifies a subgroup of elderly depressed males who may benefit from testosterone therapy...
- 5HT2A and 5HT2C receptor polymorphisms and predicting clinical response to olanzapine in schizophreniaVicki L Ellingrod
J Clin Psychopharmacol 22:622-4. 2002
- The extent of potential antihypertensive drug interactions in a Medicaid populationBarry L Carter
Division of Clinical and Administrative Pharmacy, College of Pharmacy, College of Medicine, University of Iowa, Iowa City, IA 52242, USA
Am J Hypertens 15:953-7. 2002..We evaluated the frequency of potential drug-drug interactions in patients receiving medications commonly used for hypertension...
- Anabolic steroids: a review for the clinicianEric C Kutscher
Western Missouri Mental Health Center, Kansas City, Missouri 64108, USA
Sports Med 32:285-96. 2002..This review will address the common anabolic steroid misconceptions held by many of today's athletes by providing an evaluation of the scientific literature related to AS in athletic performance...
- Anabolic steroid use in weightlifters and bodybuilders: an internet survey of drug utilizationPaul J Perry
Department of Psychiatry, College of Medicine, and the College of Pharmacy, University of Iowa, Iowa City, IA 52242 1112, USA
Clin J Sport Med 15:326-30. 2005..Prior reports of anabolic steroid use suggest polypharmacy and high doses of injectable agents...
- Osteoporosis screening and treatment in women with schizophrenia: a controlled studyJeffrey R Bishop
College of Pharmacy, University of Iowa, Iowa City, USA
Pharmacotherapy 24:515-21. 2004..e., clinical services for osteoporosis) are provided consistently to both women with schizophrenia and those without the disease...
- A critical appraisal of the utility of the serum anticholinergic activity assay in research and clinical practiceRyan M Carnahan
University of Iowa, College of Pharmacy, 415 S Pharmacy Building, Iowa City, Iowa 52242 1112, USA
Psychopharmacol Bull 36:24-39. 2002....
- Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndromeGary R Gaffney
University of Iowa College of Medicine, Iowa City, USA
J Am Acad Child Adolesc Psychiatry 41:330-6. 2002..To evaluate the efficacy and tolerability of risperidone in comparison with clonidine in the treatment of children and adolescents with Tourette's syndrome (TS)...